Deloitte Named a Leader in Life Sciences Smart Manufacturing Services by Everest Group

“The life sciences manufacturing industry, once defined by legacy IT infrastructure, fragmented data, and inefficient processes, is actively embracing Industry 4.0 principles through the adoption of advanced technologies such as analytics, AI/ML, and IoT to attain the goal of operational excellence. Currently, enterprises are investing in well-established use cases such as predictive maintenance, digital twin implementation, and quality improvement. Subsequently, they are turning to emerging use cases centered around specialty drugs and sustainable manufacturing," said Chunky Satija, Vice President at Everest Group. "Deloitte offers comprehensive services across the manufacturing value chain, and its clients appreciate the investments in acquisitions and smart factories. It addresses both current manufacturing needs and tackles innovative use cases, serving clients across geographies while leveraging robust partnerships, effective client management, and providing domain-specific talent. The maturity of manufacturing solutions has positioned Deloitte as a Leader in the Life Sciences Smart Manufacturing Services PEAK Matrix Assessment 2023."

Everest Group positioned Deloitte as one of five Leaders, with Deloitte receiving the best overall recognition than any other competitor in Market Impact and Vision & Capability due to its strength in market adoption, portfolio mix, vision and strategy, and scope of services offered. Deloitte was also recognized for its investments in developing manufacturing solutions across the life sciences value chain, such as focusing on futuristic domain use cases like cell and gene therapy and making dedicated investments like building Deloitte’s The Smart Factory @ Wichita, part of Deloitte’s network of global smart manufacturing experience centers. In addition to viewing Deloitte as a reliable strategic advisor, clients also highlight the organization’s premium pricing points, the high quality of talent, and strong technical domain knowledge. 

“We are honored to receive this acknowledgement from Everest Group,” says Laks Pernenkil, Deloitte US Life Sciences Product & Supply Operations Principal & practice leader. “Applying the lessons learned from navigating the pre-pandemic marketplace, Deloitte remains focused on leveraging our unique history of deep industry knowledge to continue working side by side with clients who are committed to innovation and sustainable growth that ultimately accelerates action and creates connections that empower a digitally enabled and equitable future of health.” 

Everest Group evaluated 16 life sciences services providers, assessing each organization’s overall vision, capability, and market impact. Leaders are recognized as a provider that delivers a balanced breadth of offerings across the life sciences manufacturing value chain, demonstrates flexibility and innovation, leverages a robust partnership ecosystem, and showcases a clear roadmap for bolstering internal capabilities. 

“As the Life Sciences sector seeks to scale its manufacturing value chain to meet the new demands of today’s market, which is impacted by supply chain disruptions, economic fluctuations, workforce/talent shortages, and more, we’re committed to advancing the business of science to help our clients drive impact. We do this by approaching each unique client challenge with Deloitte’s combination of industry experience, business strategy and products paired with technology, ” says Tim Gaus, Smart Manufacturing Business leader and principal, Deloitte Consulting LLP. “With our vision equally focused on health equity and business transformation, Deloitte is uniquely positioned to collaborate with the innovators addressing the most pressing health challenges and support leaders looking to scale operations efficiently and lead a well-being revolution—whether that is through our strategic investments, holistic ecosystems of partners, or deep industry knowledge and global reach.”